Prevalence and prognosis of ischaemic and non-ischaemic myocardial fibrosis in older adults

European Heart Journal

Volumn 40, Issue 6, 2019, Pages 529-538

  Shanbhag, Sujata M ^a   Greve, Anders M ^a,b   Aspelund, Thor ^c,d   Schelbert, Erik B ^a,e   Cao, J Jane ^a,f   Danielsen, Ragnar ^d   Porgeirsson, Guðmundur ^d   Sigurðsson, Sigurður ^c   Eiríksdóttir, Guðný ^c   Harris, Tamara B ^g   Launer, Lenore J ^g   Guðnason, Vilmundur ^c,d   Arai, Andrew E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^c ICELANDIC HEART ASSOCIATION   (Iceland)

^d UNIVERSITY OF ICELAND   (Iceland)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^f STONY BROOK UNIVERSITY   (United States)

^g NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Fibrosis; Gadolinium; Myocardial infarction; Non ischaemic cardiomyopathy; Prognosis

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL OUTCOME; CLINICAL STUDY; COHORT ANALYSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENOTYPE ENVIRONMENT INTERACTION; GERIATRIC PATIENT; HAZARD RATIO; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ISCHEMIC MYOCARDIAL FIBROSIS; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; VERY ELDERLY; CARDIAC MUSCLE; CARDIOMYOPATHY; DIAGNOSTIC IMAGING; FIBROSIS; HEART; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

AGED; AGED, 80 AND OVER; CARDIOMYOPATHIES; FEMALE; FIBROSIS; HEART; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PREVALENCE; PROGNOSIS;

EID: 85061491793     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehy713     Document Type: Article

References (34)

1. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB; American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006;113:1807-1816.
2. Gerber BL, Edvardsen T, Pierard LA, Saraste A, Knuuti J, Maurer G, Habib G, Lancellotti P. The year 2014 in the European Heart Journal-Cardiovascular Imaging: part II. Eur Heart J Cardiovasc Imaging 2015;16:1180-1184.
3. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100: 1992-2002.
4. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005;26:1461-1474.
5. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129-2200.
6. Kim EK, Chattranukulchai P, Klem I. Cardiac magnetic resonance scar imaging for sudden cardiac death risk stratification in patients with non-ischemic cardiomyopathy. Korean J Radiol 2015;16:683-695.
7. Poyhonen P, Kivisto S, Holmstrom M, Hanninen H. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early riskstratification of nonischemic cardiomyopathy: a cohort study. BMC Cardiovasc Disord 2014;14:110.
8. Almehmadi F, Joncas SX, Nevis I, Zahrani M, Bokhari M, Stirrat J, Fine NM, Yee R, White JA. Prevalence of myocardial fibrosis patterns in patients with systolic dysfunction: prognostic significance for the prediction of sudden cardiac arrest or appropriate implantable cardiac defibrillator therapy. Circ Cardiovasc Imaging 2014;7:593-600.
9. Wong TC, Piehler KM, Zareba KM, Lin K, Phrampus A, Patel A, Moon JC, Ugander M, Valeti U, Holtz JE, Fu B, Chang CC, Mathier M, Kellman P, Butler J, Gheorghiade M, Schelbert EB. Myocardial damage detected by late gadolinium enhancement cardiovascular magnetic resonance is associated with subsequent hospitalization for heart failure. J Am Heart Assoc 2013;2:e000416.
10. Harris TB, Launer LJ, Eiriksdottir G, Kjartansson O, Jonsson PV, Sigurdsson G, Thorgeirsson G, Aspelund T, Garcia ME, Cotch MF, Hoffman HJ, Gudnason V. Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. Am J Epidemiol 2007;165:1076-1087.
11. Schelbert EB, Cao JJ, Sigurdsson S, Aspelund T, Kellman P, Aletras AH, Dyke CK, Thorgeirsson G, Eiriksdottir G, Launer LJ, Gudnason V, Harris TB, Arai AE. Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA 2012;308:890-896.
12. Danielsen R, Thorgeirsson G, Einarsson H, Olafsson O, Aspelund T, Harris TB, Launer L, Gudnason V. Prevalence of heart failure in the elderly and future projections: the AGES-Reykjavik study. Scand Cardiovasc J 2017;51: 183-189.
13. Hsu LY, Ingkanisorn WP, Kellman P, Aletras AH, Arai AE. Quantitative myocardial infarction on delayed enhancement MRI. Part II: clinical application of an automated feature analysis and combined thresholding infarct sizing algorithm. J Magn Reson Imaging 2006;23:309-314.
14. Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, Gatehouse PD, Arai AE, Friedrich MG, Neubauer S, Schulz-Menger J, Schelbert EB. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 2013;15:92.
15. Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, Kellman P, Shroff SG, Schwartzman DS, Mulukutla SR, Simon MA, Schelbert EB. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 2012; 126:1206-1216.
16. Schelbert EB, Piehler KM, Zareba KM, Moon JC, Ugander M, Messroghli DR, Valeti US, Chang CC, Shroff SG, Diez J, Miller CA, Schmitt M, Kellman P, Butler J, Gheorghiade M, Wong TC, Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage. J Am Heart Assoc 2015;4:e002613.
17. Roberts WC, Siegel RJ, McManus BM. Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 1987;60:1340-1355.
18. Schelbert EB, Hsu LY, Anderson SA, Mohanty BD, Karim SM, Kellman P, Aletras AH, Arai AE. Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart. Circ Cardiovasc Imaging 2010;3:743-752.
19. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977;56:786-794.
20. Salisbury AC, Shapiro BP, Martinez MW. Extensive myocardial and mitral annular calcification leading to mitral regurgitation and restrictive cardiomyopathy: an unusual case of caseous calcification of the mitral annulus. J Cardiovasc Comput Tomogr 2009;3:351-353.
21. Hajsadeghi F, Ahmadi N, Eshaghian S, Budoff M. Porcelain heart. J Cardiovasc Comput Tomogr 2011;5:183-185.
22. Nance JW Jr, Crane GM, Halushka MK, Fishman EK, Zimmerman SL. Myocardial calcifications: pathophysiology, etiologies, differential diagnoses, and imaging findings. J Cardiovasc Comput Tomogr 2015;9:58-67.
23. Hamirani YS, Nasir K, Blumenthal RS, Takasu J, Shavelle D, Kronmal R, Budoff M. Relation of mitral annular calcium and coronary calcium (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol 2011;107:1291-1294.
24. Revilla A, Sevilla T, Sanchez I, Rodriguez M, San RJA. Full calcium jacket: massive idiopathic myocardial calcification by cardiovascular magnetic resonance and cardiac CT. Eur Heart J Cardiovasc Imaging 2012;13:627.
25. Warren BA, Yong JL. Calcification of the aortic valve: its progression and grading. Pathology 1997;29:360-368.
26. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005;111:3316-3326.
27. Yater WM, Cornell VH. Heart block due to calcareous lesions of the bundle of His-review and report of a case with detailed histopathologic study. Ann Intern Med 1935;8:777-789.
28. Nestico PF, Depace NL, Morganroth J, Kotler MN, Ross J. Mitral annular calcification-clinical, patho-physiology, and echocardiographic review. Am Heart J 1984;107:989-996.
29. Lindman BR, Clavel MA, Mathieu P, Iung B, Lancellotti P, Otto CM, Pibarot P. Calcific aortic stenosis. Nat Rev Dis Primers 2016;2:16006.
30. Barasch E, Gottdiener JS, Larsen EK, Chaves PH, Newman AB, Manolio TA. Clinical significance of calcification of the fibrous skeleton of the heart and aortosclerosis in community dwelling elderly. The Cardiovascular Health Study (CHS). Am Heart J 2006;151:39-47.
31. Patel AR, Addetia K. Prediction of prognosis in pulmonary hypertension using CMR: what happens where the right and left ventricles meet? JACC Cardiovasc Imaging 2014;7:1218-1220.
32. Bradlow WM, Assomull R, Kilner PJ, Gibbs JS, Sheppard MN, Mohiaddin RH. Understanding late gadolinium enhancement in pulmonary hypertension. Circ Cardiovasc Imaging 2010;3:501-503.
33. Lie JT, Hammond PI. Pathology of the senescent heart: anatomic observations on 237 autopsy studies of patients 90 to 105 years old. Mayo Clin Proc 1988;63: 552-564.
34. Schwartz CJ, Mitchell JR. The relation between myocardial lesions and coronary artery disease. I. An unselected necropsy study. Br Heart J 1962;24:761-786.